Aharon G Freud, MD, PhD
College of Medicine
>Cancer ● Leukemia ● Lymphoma ● Lymphoma, B-Cell ● Graft vs Host Disease ● Lymphoma, Follicular
As a member of the Leukemia Research Program at the OSUCCC – James, Aharon G. Freud, MD, PhD, seeks to understand how natural killer (NK) cells develop in healthy and diseased settings so that processes can be modulated to promote effective NK cell anticancer functions.He is the co-holder of a U.S. patent related to CD34+ cells and their methods of use. His recent research includes investigating the role of the Epstein-Barr virus in NK-cell lymphoma, as well as studies exploring innate lymphoid cell and NK cell development in human tissues. Dr. Freud, an assistant professor in the Department of Pathology at Ohio State, has authored or co-authored articles appearing in such prestigious publications as Immunity, The Journal of Clinical Investigation, Blood, and The Journal of Experimental Medicine. He also has authored a half-dozen book chapters, including “Purification of Human NK Cell Developmental Intermediates from Lymph Nodes and Tonsils” in Natural Killer Cell Protocols, a volume in the Methods in Molecular Biology series.